Group items tagged

The Ontario Genomics Institute has given funding to MaRS life sciences client, ArcticDX. They'll use the money for studies in preparation for a Food and Drug Administration approval for their product. The funding comes through its Pre-Commercialization Business Development Fund (PBDF)

Canadian Patents and Copyrights

The mission of the Canadian Intellectual Property Office (CIPO) is to accelerate Canada's economic development by: * Fostering the use of intellectual property systems and the exploitation of intellectual property information; * Encouraging invention, innovation, and creativity in Canada; * Administering Canada's intellectual property systems (patents, trade-marks, copyrights, industrial designs, and integrated circuit topographies); and * Promoting Canada's international intellectual property interests. The web site includes comprehensive databases for trade-marks, copyrights, industrial designs, etc. It also has information that is useful for first time inventors, including a section for learning about IP, and a range of publications such as guides to trade-marks, copyrights, and patents.

Communitech, the Ottawa Centre for Research and Innovation, and the MaRS Discovery District have ageed to work together to help the province compete more effectively against countries like India and China. These three companies partnership will function under the name MaRS Network. May 29, 2005

Communitech, the Ottawa Centre for Research and Innovation, and the MaRS Discovery District have ageed to work together to help the province compete more effectively against countries like India and China. These three companies partnership will function under the name MaRS Network.

(Deutsch Bundesbank) This paper attempts to evaluate the macroeconomic impact of venture capital (VC). The authors test the assumption that Venture Capital is similar in several respects to business R&D performed by large firms and therefore contributes to economic growth through two main channels: innovation and absorptive capacity.

(Deutsch Bundesbank)\nThis paper attempts to evaluate the macroeconomic impact of venture capital (VC). The authors test the assumption that Venture Capital is similar in several respects to business R&D performed by large firms and therefore contributes to economic growth through two main channels: innovation and absorptive capacity.

From Publishers Weekly\nChristensen (The Innovator's Dilemma) analyzes the strategies that allow corporations to successfully grow new businesses and outpace the other players in the marketplace. Christensen's earlier book examined how focusing on profits can destroy even well-run corporations, while this book focuses on companies expanding by being "disruptors" who are able to outpace their entrenched competition. The authors (Christensen is a professor at Harvard Business School and Raynor, a director at Deloitte Research) examine the nine business decisions integral to growth, including product development, organizational structure, financing and key customer base. They cite such companies as IBM, AT&T, Sony, Microsoft and others to illustrate their points. Generally, the writing is clear and specific. For example, in discussing whether a company has the resources necessary for growth, the authors say, "In order to be confident that managers have developed the skills required to succeed at a new assignment, one should examine the sorts of problems they have wrestled with in the past. It is not as important that managers have succeeded with the problem as it is for them to have wrestled with it and developed the skills and intuition for how to meet the challenge successfully the next time around"; they then provide a real-life example of a software company. Similar important strategies give readers insights that they can use in their own workplaces. People looking for quick fixes may find the charts, diagrams and extensive footnotes daunting, but readers familiar with more technical business management tomes will find this one both stimulating and beneficial.

Interview with Dr. Rafael Hofstein about how MaRS Innovation will help to accelerate the pace in turning ideas into meaningful products which in turns help the healthcare system. Dr. Hofstein also talked about the 2 medical products that were brought to market: i) Umbilical Cord Stem Cell Technology ii) Diabetic Wound Healing Technology."

Toronto's MaRS Innovation Names Raphael (Rafi) Hofstein President and CEO.

Raphael (Rafi) Hofstein has been appointed the president and CEO of MaRS Innovation.

MaRS is held up as an example of what an "old" city can do if they're ambitious and just decide to do something. Like when Toronto decided that it wanted to gain ground in the science knowledge economy. Nevermind that AGAIN MaRS is misrepresented as a biotech incubator -- I suppose there are worse things to be called. But still part of an ambitious, big-thinking plan to improve the science, tech and social outcomes of the economy. Amen.

Tim Rowe's blog takes a look at exploring what its future might look like by building "a showcase for future living. Mention of MaRS having the best biotech space.

Tim Rowe's blog takes a look at exploring what its future might look like by building "a showcase for future living. Mention of MaRS having the best biotech space.

Story about Certo-Ex which have a device that streamlines sampling and can revolution the time and money spent by pharmaceutical, environmental and food industries. Mention of how TiEQuest had given them access to network with MaRS.

Story about Certo-Ex which have a device that streamlines sampling and can revolution the time and money spent by pharmaceutical, environmental and food industries. Mention of how TiEQuest had given them access to network with MaRS. Jan 14, 2009

Blog mentions of a presentation where Charles Plant spoke about Venure Capital and how you need to have a compelling business case to maximize and obtain favourable conditions from VCs. March 3, 2009

Blog mentions of a presentation where Charles Plant spoke about Venure Capital and how you need to have a compelling business case to maximize and obtain favourable conditions from VCs.

Almost two years after Ottawa's 'Innovation Hub' was first proposed, documents show the province has serious concerns as to whether the Hub can garner enough private-sector support or will create enough jobs to qualify for funding.

Almost two years after Ottawa's 'Innovation Hub' was first proposed, documents show the province has serious concerns as to whether the Hub can garner enough private-sector support or will create enough jobs to qualify for funding. Feb 9, 2009

McGuinty Government on track to turn Cleantech into jobs of the future. Mention of MaRS Mentorship and Entrepreneurship Program as one of the programs that participated in the Cleantech Growth & Go-to-Market Report.

McGuinty Government on track to turn Cleantech into jobs of the future. Mention of MaRS Mentorship and Entrepreneurship Program as one of the programs that participated in the Cleantech Growth & Go-to-Market Report. Feb 17, 2009

Liberal Critic for Industry, Science and Technology Marc Garneau will be traveling across Canada to consult with Canadians on how to revitalize Canada's scientific industry and will include MaRS Discovery District on his tour.

Liberal Critic for Industry, Science and Technology Marc Garneau will be traveling across Canada to consult with Canadians on how to revitalize Canada's scientific industry and will include MaRS Discovery District on his tour. April 13, 2009

Ontario announced a new fund to attract and retain world-leading genomics researchers in the province.The $100-million Global Leadership Round in Genomics and Life Sciences will support globally-significant, collaborative research projects that are headquartered in Ontario. Dr. Evans is quoted stating that "the government must recognize that Ontario must invest in strong life science clusters."

Ontario announced a new fund to attract and retain world-leading genomics researchers in the province.The $100-million Global Leadership Round in Genomics and Life Sciences will support globally-significant, collaborative research projects that are headquartered in Ontario. Dr. Evans is quoted stating that "the government must recognize that Ontario must invest in strong life science clusters."

Several high-rise sites in the downtown core have been temporarily shut down as the developers wait for the economic climate to improve. Mention of MaRS Discovery Districts' expansion on hold.

Consider the two faces of the global innovation movement. Company A, having grown through acquisition, produces multiple brands for multiple markets and operates a worldwide network of research and product development centers. Each of its R&D sites was initially responsible for its own brands and local market, but with globalization these distinctions have lost their importance. Company B, on the other hand, was built largely through internal growth and has two global brands. It operates one primary R&D center supported by a handful of special-purpose sites around the world. This comparatively sparse network has helped Company B win wide admiration for the efficiency of its engineering. Because expanding the number of nodes in a network exponentially increases its complexity, it is not surprising that Company A's R&D structure is more expensive to operate. Company A has considered closing some sites, but has resisted doing so because it fears losing capabilities and insights, and roiling local markets. Meanwhile, incremental budget cuts have chipped away at engineer and supplier morale. Having built its network to maximize the value associated with market access, it is now forced to manage the network for cost. Most global innovation networks look like Company A's - and suffer the same problems. Company B's R&D structure is clearly more productive, but it is not necessarily ideal either. Its network might be too compact, limiting access to knowledge that could maximize performance. Thus, to identify principles and practices for creating a truly well-designed innovation network, Booz Allen Hamilton and INSEAD, the international business school, surveyed R&D leaders in 186 companies from 17 industry sectors in 19 nations in 2005. The survey results, and our own experience, suggest one central truth: Organizations benefit when they configure their innovation networks for cost and manage them for value.

GEM is a non-profit consortium that compiles international data on entrepreneurial activity. According to its' Vision & Values, its' goal is to develop international standards for social survey based research methodologies in entrepreneurship. GEM Global Reports compare and contrast Canadian entrepreneurial activity with 10 to 42 (2006) other countries in the world. Economic development, characteristics, institutions, sponsorships, and team work are all examined and interpreted scientifically. Ownership, income, opportunity, innovativeness, sectors, and demographics are all put into global perspectives. Check out the reports to see where Canadian entrepreneurs stand!

As McKinsey & Company's business journal, The McKinsey Quarterly offers public, non-profit, and private management "new ways of thinking." Focus is placed on strategy, corporate finance, governance, economic studies, IT, organization, marketing, and operations. Articles are free (dating back to 1992), a selection of which are available with free registration. Some "premium" articles are available to Premium Members (paid subscribers).